OBJECTIVE: To address the maternal and neonatal risks of both depression and
antidepressant exposure and develop algorithms for periconceptional and antenatal …

Importance Untreated depression during pregnancy has been associated with increased
morbidity and mortality for both mother and child and, as such, optimal treatment strategies …

Context Maternal depressive symptoms during pregnancy have been reported in some, but
not all, studies to be associated with an increased risk of preterm birth (PTB), low birth …

Context Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants
and maternal depression both alter neonatal health, and distinguishing the effects of each …

Objective: Selective serotonin reuptake inhibitor (SSRI) use during pregnancy incurs a low
absolute risk for major malformations; however, other adverse outcomes have been …

Importance Posttraumatic stress disorder (PTSD) occurs in about 8% of pregnant women.
Stressful conditions, including PTSD, are inconsistently linked to preterm birth. Psychotropic …

OBJECTIVE: This study was undertaken to provide information on the prevalence of use of
antidepressant drugs among pregnant women in the United States. STUDY DESIGN: A …

Objectives To examine the relationship between antidepressant use in pregnancy and low
birth weight (LBW) and preterm birth (PTB). Data Sources and Study Selection We searched …

Objective: Depression is often not optimally treated during pregnancy, partially because of
conflicting data regarding antidepressant medication risk. This meta-analysis was conducted …

Objective: Conflicting reports on potential risks of antidepressant exposure during gestation
for the infant have been reported in the literature. This systematic review and meta-analysis …